What is primary thyroid lymphoma?
Primary thyroid lymphoma is a cancer of the immune system that starts in the thyroid gland. The thyroid is a butterfly-shaped gland at the front of the neck that makes hormones controlling the body’s metabolism. Lymphoma is a cancer of lymphocytes, white blood cells that normally help fight infection.
The thyroid does not usually contain much lymphoid tissue. In people with long-standing Hashimoto’s thyroiditis, however, the immune system attacks the thyroid and fills it with lymphocytes. Over many years, one of these lymphocytes can become cancerous. This explains why most people with thyroid lymphoma also have evidence of Hashimoto’s thyroiditis (Travaglino et al., 2020).
Primary thyroid lymphoma is rare. It accounts for only a small proportion of thyroid cancers and of lymphomas that arise outside the lymph nodes (Stein and Wartofsky, 2013). It mostly affects women over 60. The typical sign is a neck lump or goitre that grows quickly over weeks, sometimes causing difficulty swallowing or breathing.
The two main types are diffuse large B-cell lymphoma (DLBCL), which is fast-growing, and MALT lymphoma, which is slow-growing. Unlike most thyroid cancers, thyroid lymphoma is usually treated with chemotherapy, immunotherapy and radiotherapy rather than major surgery. Many people are cured, especially when the disease is confined to the neck.
1. Key facts at a glance
| Feature | Details |
|---|---|
| Type of cancer | Non-Hodgkin lymphoma arising in the thyroid |
| How common | Rare; a small fraction of thyroid cancers |
| Who is affected | Mostly women, usually over 60 |
| Main risk factor | Hashimoto’s thyroiditis |
| Usual first sign | A rapidly enlarging neck lump or goitre |
| Main types | Diffuse large B-cell lymphoma, MALT lymphoma |
| Diagnosis | Ultrasound and biopsy, often core needle biopsy |
| Main treatment | Chemoimmunotherapy (R-CHOP) and/or radiotherapy |
| Outlook | Good for MALT lymphoma; more variable for DLBCL |
2. Types
| Type | Share of cases | Behaviour | Usual treatment |
|---|---|---|---|
| Diffuse large B-cell lymphoma (DLBCL) | The most common type | Aggressive, fast-growing | R-CHOP chemoimmunotherapy, often with radiotherapy |
| MALT lymphoma (extranodal marginal zone lymphoma) | The second most common | Slow-growing | Radiotherapy alone or surgery for localised disease |
| Mixed DLBCL and MALT | Some cases | Treated as DLBCL | As for DLBCL |
| Follicular lymphoma | Uncommon | Usually slow-growing | Radiotherapy or other options |
| Other types (Hodgkin, Burkitt, T-cell) | Rare | Variable | Specific regimens |
In a 40-year series from a UK lymphoma centre, 50 of 70 patients had DLBCL and 13 had MALT lymphoma (Alzouebi et al., 2012).
MALT and DLBCL compared
| Feature | MALT lymphoma | DLBCL |
|---|---|---|
| Growth | Slow, over months or years | Rapid, over weeks |
| Hashimoto’s thyroiditis | Very common | Common, but less so |
| Pressure symptoms | Less frequent | More frequent |
| Spread beyond the neck | Uncommon | More likely |
| Treatment | Local treatment often sufficient | Systemic treatment needed |
| Outlook | Very good | Good when localised; poorer when advanced |
3. Causes and risk factors
| Risk factor | Notes |
|---|---|
| Hashimoto’s thyroiditis | Found in about 79% of patients when any evidence is counted (Travaglino et al., 2020) |
| Female sex | Reflects the higher rate of Hashimoto’s in women |
| Age over 60 | Median age about 70 in the Sheffield series |
| Long-standing immune activity in the thyroid | Chronic stimulation of lymphocytes |
The link with Hashimoto’s thyroiditis
A pooled analysis of over 1,300 cases found evidence of Hashimoto’s thyroiditis in roughly four out of five patients. It was found more often with MALT lymphoma than with DLBCL. Only about half of these patients had been known to have the condition before their lymphoma was found (Travaglino et al., 2020).
Hashimoto’s is very common, and the great majority of people with it never develop lymphoma. However, people with Hashimoto’s should report a new or rapidly growing neck swelling promptly.
4. How does it look
On ultrasound
| Feature | Description |
|---|---|
| Pattern | A large, very dark (hypoechoic) area, sometimes involving the whole gland |
| Posterior enhancement | Brighter echoes behind the mass, a feature suggesting lymphoma (Stein and Wartofsky, 2013) |
| Background gland | Changes of thyroiditis |
| Lymph nodes | Enlarged neck nodes in some patients |
Other imaging
| Test | What it shows |
|---|---|
| CT of the neck and chest | Size of the mass and pressure on the windpipe |
| PET-CT | Stage and spread beyond the thyroid |
Under the microscope
| Type | Appearance |
|---|---|
| DLBCL | Sheets of large abnormal B cells that replace the thyroid tissue |
| MALT lymphoma | Small lymphocytes infiltrating thyroid follicles, forming “lymphoepithelial lesions” |
| Supporting tests | Immunostains (CD20 and others), flow cytometry and genetic tests to show the cells are cancerous |
5. Symptoms
Common symptoms
- A rapidly growing lump in the front of the neck
- Difficulty swallowing
- A hoarse voice
- Breathlessness or noisy breathing caused by pressure on the windpipe
Less common symptoms
| Symptom | Notes |
|---|---|
| Fever, drenching night sweats, weight loss | So-called B symptoms; more common with DLBCL |
| Tiredness, weight gain, feeling cold | Underactive thyroid (hypothyroidism) |
| Swollen glands elsewhere | Spread beyond the thyroid |
| Swelling of the face and neck veins | Pressure on large veins in the chest |
When to seek urgent help
Seek urgent medical help for difficulty breathing, noisy breathing (stridor) or inability to swallow. A neck lump that grows over weeks should be assessed quickly, especially in someone with Hashimoto’s thyroiditis.
6. Diagnosis
| Test | Purpose |
|---|---|
| Neck examination | Size, firmness and fixation of the lump |
| Thyroid function and antibodies | Hypothyroidism and Hashimoto’s thyroiditis |
| Neck ultrasound | Characterises the lump |
| Fine-needle aspiration with flow cytometry | Can diagnose lymphoma in experienced hands |
| Core needle biopsy | Provides more tissue; often preferred |
| Surgical biopsy | When needle tests are inconclusive |
| PET-CT | Staging |
| Blood tests (LDH, blood count) | Assess disease activity and risk |
| Bone marrow biopsy | Selected cases |
A fine-needle sample may be enough to make the diagnosis when flow cytometry and experienced pathologists are available. Confirmation by biopsy remains essential (Stein and Wartofsky, 2013).
Distinguishing lymphoma from anaplastic thyroid cancer
| Feature | Thyroid lymphoma | Anaplastic thyroid cancer |
|---|---|---|
| Growth | Rapid | Very rapid |
| Background | Hashimoto’s thyroiditis | Often a long-standing goitre |
| Treatment | Chemotherapy and radiotherapy | Surgery, radiotherapy, targeted drugs |
| Outlook | Often curable | Very poor |
Because the treatments and outlook differ so much, an accurate biopsy is vital.
Staging
| Stage | Meaning |
|---|---|
| Stage IE | Lymphoma limited to the thyroid |
| Stage IIE | Thyroid plus lymph nodes on the same side of the diaphragm |
| Stage IIIE-IV | Spread on both sides of the diaphragm or to other organs |
About half of people with thyroid lymphoma have stage IE disease (Tang et al., 2024).
7. Treatment
Treatment depends on the type and stage of the lymphoma.
| Situation | Typical treatment |
|---|---|
| Localised MALT lymphoma | Radiotherapy to the neck, or surgery if already fully removed |
| Advanced MALT lymphoma | Rituximab-based treatment or watchful waiting |
| Localised DLBCL | Short-course R-CHOP followed by radiotherapy, or R-CHOP alone |
| Advanced DLBCL | Six cycles of R-CHOP, with radiotherapy in some cases |
| Airway compression | Steroids and urgent treatment; rarely an airway procedure |
Radiotherapy can control localised MALT lymphoma, while aggressive types or widespread disease need chemotherapy combined with radiotherapy (Stein and Wartofsky, 2013). In the Sheffield series, radiotherapy alone was enough for stage I-II low-grade disease if treatment was needed after surgery (Alzouebi et al., 2012).
Role of surgery
| Situation | Notes |
|---|---|
| Diagnosis | Surgical biopsy if needle biopsy is inconclusive |
| Stage IE disease | A large SEER analysis found surgery alone gave similar disease-specific survival to other treatments in selected patients (Tang et al., 2024) |
| Advanced or aggressive disease | Surgery is not the main treatment |
In the study by Tang and colleagues, surgery alone also meant fewer complications, shorter treatment and lower costs in a smaller hospital cohort. This option is generally considered for small, localised tumours that can be removed easily, especially MALT lymphoma.
R-CHOP explained
| Drug | Type |
|---|---|
| R – Rituximab | Antibody targeting CD20 on B cells |
| C – Cyclophosphamide | Chemotherapy |
| H – Doxorubicin (hydroxydaunorubicin) | Chemotherapy |
| O – Vincristine (Oncovin) | Chemotherapy |
| P – Prednisolone | Steroid |
What a course of treatment looks like
| Phase | What happens | Typical length |
|---|---|---|
| Diagnosis and staging | Ultrasound, biopsy, PET-CT, blood tests | 1-3 weeks |
| Chemoimmunotherapy | R-CHOP every 2-3 weeks, given as a day-case infusion | About 2-5 months |
| Interim scan | PET-CT to check response | Midway or at the end |
| Radiotherapy | Weekday sessions to the neck | About 2-4 weeks |
| End-of-treatment scan | Confirms remission | 6-8 weeks after treatment |
When the airway is at risk
A fast-growing thyroid lymphoma can narrow the windpipe. In this situation, doctors act quickly. High-dose steroids often shrink the lymphoma within days, and chemotherapy is started urgently once the biopsy is taken.
Very rarely, a tracheostomy or airway stent is needed. Ask your team what warning signs to watch for while waiting for results.
Side effects
| Treatment | Possible side effects |
|---|---|
| R-CHOP | Infection risk, hair loss, tiredness, nerve tingling, nausea, heart effects with doxorubicin |
| Neck radiotherapy | Sore throat, difficulty swallowing, skin redness, dry mouth |
| Long term after radiotherapy | Underactive thyroid, neck stiffness |
| Thyroid surgery | Hoarse voice, low calcium, need for thyroid hormone |
8. Outlook (prognosis)
| Factor | Effect |
|---|---|
| MALT lymphoma | Very good outlook |
| DLBCL | Good when localised; poorer when advanced |
| Stage IE or IIE | Better outlook |
| B symptoms, high LDH, older age, poor fitness | Poorer outlook |
| Pressure on the airway at diagnosis | Linked with more aggressive disease |
Survival in the Sheffield series
| Type | Five-year survival |
|---|---|
| DLBCL | 45% |
| MALT lymphoma | 62% |
| Indolent B-cell lymphoma (other) | 75% |
These figures come from patients treated over four decades, many before rituximab was available, and from an older group with a median age of about 70 (Alzouebi et al., 2012). Results with modern treatment are generally better.
9. Follow-up
| Follow-up | Purpose |
|---|---|
| Clinic visits every 3-6 months for 2 years | Check for relapse and side effects |
| Then every 6-12 months | Longer-term monitoring |
| Thyroid function tests | Many patients need thyroid hormone replacement |
| Imaging | Only if symptoms or signs suggest relapse |
| Heart checks | After doxorubicin, if symptoms develop |
10. Living with thyroid lymphoma
- Take thyroid hormone tablets as prescribed, and have regular blood tests
- Report fever promptly during chemotherapy
- Use soft foods and painkillers if radiotherapy makes swallowing sore
- Look after your mouth and teeth after neck radiotherapy
- Stay active to help with fatigue
- Have the flu and other recommended vaccines, as advised by your team
- Report a new neck lump, swallowing difficulty or night sweats
- Seek support from lymphoma charities and patient groups
11. Frequently asked questions
| Question | Answer |
|---|---|
| Is thyroid lymphoma the same as thyroid cancer? | It is a cancer in the thyroid, but it is a lymphoma, so it is treated differently |
| Did my Hashimoto’s cause it? | It raises the risk, but very few people with Hashimoto’s develop lymphoma |
| Will my thyroid be removed? | Usually not; surgery is mainly used for diagnosis or small localised disease |
| Can it be cured? | Yes, many people are cured, especially with localised disease |
| Will I need thyroid tablets? | Often, either because of Hashimoto’s or after radiotherapy |
| Can it come back? | Yes, so regular follow-up is important; relapses can usually be treated |
| Can I keep working? | Many people work part-time during treatment, depending on how they feel |
| Is it inherited? | No |
| Should my family be checked for Hashimoto’s? | Not routinely; anyone with thyroid symptoms should see their doctor |
| Will I lose my hair? | Usually with R-CHOP, but it grows back after treatment |
12. Questions to ask your care team
- What type of thyroid lymphoma do I have?
- What stage is it?
- Do I need chemotherapy, radiotherapy or both?
- Is surgery an option in my case?
- How will treatment affect my thyroid function?
- What side effects should I watch for?
- What follow-up will I need?
- Who do I contact if I have breathing or swallowing problems?
- Will I need thyroid hormone tablets long term?
Resources
- Alzouebi, M. et al. (2012) ‘Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre’, International Journal of Oncology, 40(6), pp. 2075-2080.
- Stein, S.A. and Wartofsky, L. (2013) ‘Primary thyroid lymphoma: a clinical review’, Journal of Clinical Endocrinology and Metabolism, 98(8), pp. 3131-3138.
- Tang, Y. et al. (2024) ‘Surgery is a viable treatment option for stage IE primary thyroid lymphoma’, Annals of Surgical Oncology, 31(2), pp. 1108-1115.
- Travaglino, A. et al. (2020) ‘Hashimoto thyroiditis in primary thyroid non-Hodgkin lymphoma’, American Journal of Clinical Pathology, 153(2), pp. 156-164.
- National Cancer Institute (2026) Non-Hodgkin Lymphoma Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq (Accessed: October 2026).
Prepared by the editorial team, October 2026.